CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 68 enrolled
Drug / intervention
Scintigraphyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04704349
NCT04704349N/ACompleted
CompareCT.gov

Latest Imaging SPECT System Evaluation Phase 1

Centre Hospitalier Régional d'Orléans·interventional·Posted Jan 11, 2021·Updated Nov 3, 2021

In Brief

A clinical study evaluating Scintigraphy for Rheumatic Disease and 8 related conditions. Completed, enrolled 68 participants across 1 site.

Detailed Summary

Monocentric study for the evaluation of a whole body CZT scintigraphy system.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRheumatic Disease, Neoplasms, Parathyroid Diseases, Pulmonary Embolism, Heart Diseases, Thyroid Diseases, Kidney Diseases, Dementia, Parkinsonian Disorders
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJan 11, 2021
Enrollment StartOct 5, 2020
Primary CompletionJan 27, 2021
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 5.5 years ago

Interventions

Scintigraphyradiation

The scintigraphy of the patients will be carried out on 2 distinct devices and the images obtained will be compared.